Efficacy of liraglutide 3 mig therapy in obesity and associated diseases

by K. A. Komshilova, E. A. Troshina
Published 2018-03-01

Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction

by K. A. Komshilova, E. A. Troshina
Published 2018-04-01

EARLY EXPERIENCE OF GPP-1 LIRAGLUTIDE 3.0 MG ANALOGUE IN RUSSIA AND ITS EFFECT ON METABOLIC RISK FACTORS IN OBESITY PATIENTS

by K. A. Komshilova, E. A. Troshina, E. V. Ershova, O. V. Logvinova
Published 2017-12-01

Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity

by K A Komshilova, E A Troshina, E V Ershova, N V Mazurina, N M Platonova
Published 2014-10-01